Note also that they say we have to roll it out faster since it may not work
against new strains. Meaning pharma wont make as much money if people won’t
take it if they find out it doesn’t really help
Sent from my iPhone
On Jan 16, 2021, at 10:52 AM, rhelkins (Redacted sender "rhelkins" for DMARC)
<dmarc-noreply@xxxxxxxxxxxxx> wrote:
https://www.washingtonpost.com/opinions/2021/01/15/vaccines-america-must-balance-speed-equity/
